ロード中...
Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension
BACKGROUND: Pulmonary hypertension (PH) is a life-threatening disorder characterized by increased pulmonary artery pressure, remodeling of the pulmonary vasculature, and right ventricular failure. Loss of endothelium-derived nitric oxide (NO) and prostacyclin (PGI(2)) contributes to PH pathogenesis...
保存先:
主要な著者: | , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
2014
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4124037/ https://ncbi.nlm.nih.gov/pubmed/24899690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.114.009751 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|